FDA Commissioner Marty Makary’s initiative promises ultra-fast reviews for drugs aligning with “national priorities.” ...
Dr. Martin Makary testifies during his confirmation hearing before the Senate Committee on Health, Education, Labor, and Pensions Committee on March 06, 2025, in Washington, DC. This story was ...
WASHINGTON (AP) — U.S. regulators will begin offering faster reviews to new medicines that administration officials deem as promoting “the health interests of Americans,” under a new initiative ...
WASHINGTON (AP) — U.S. regulators will begin offering faster reviews to new medicines that administration officials deem as promoting “the health interests of Americans,” under a new initiative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results